Chemed (CHE) earnings per share (EPS)

Earnings per share · fiscal 2025
$18.34

Chemed (CHE) reported diluted earnings per share of $18.34 in fiscal 2025 (the year ended December 31, 2025). That is 7.8% lower than the $19.89 of fiscal 2024. Figures as of 17 Nov 2026, 22:51 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings per share, fiscal 2025
$18.34
Change on fiscal 2024
−7.8%
Growth, 5 years
−1.2% a year
Growth, 10 years
+11.2% a year
Highest on record
$19.89fiscal 2024
Lowest on record
$2.88fiscal 2008
Fiscal years on record
182008–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Chemed earnings per share (EPS), in more detail

Over the five fiscal years to 2025 diluted earnings per share shrank at a compound 1.2% a year; over ten years the rate was 11.2% a year. Across the 18 fiscal years on record (2008–2025), the highest was $19.89 in fiscal 2024 and the lowest $2.88 in fiscal 2008.

History · 18 fiscal years

Earnings per share by fiscal year

Chemed earnings per share (EPS), year by year

Chemed (CHE) earnings per share (EPS) by fiscal year
Fiscal yearEarnings per shareChangeYear ended
2025$18.34 7.8% down
2024$19.89 10.9% up
2023$17.93 8.5% up
2022$16.53 1.9% down
2021$16.85 13.5% down
2020$19.48 46.4% up
2019$13.31 8.8% up
2018$12.23 108.7% up
2017$5.86 9.6% down
2016$6.48 2.4% up
2015$6.33 13.6% up
2014$5.57 33.9% up
2013$4.16 10.0% down
2012$4.62 12.7% up
2011$4.10 15.5% up
2010$3.55 9.6% up
2009$3.24 12.5% up
2008$2.88—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

How to read it

It shows how much profit stands behind each share, so it rises when profit grows or when buybacks shrink the share count.

Earnings per share at health care companies of similar size

Earnings per share of Chemed and comparable companies
CompanyEarnings per shareFiscal year
Immunovant IMVT-$2.772026
Axsome Therapeutics AXSM-$3.682025
Chemed CHE$18.342025
Oruka Therapeutics ORKA-$1.852025
Arrowhead Pharmaceuticals ARWR-$0.012025
MSA Safety MSA$7.092025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on CHE

Chemed, figure by figure

Chemed (CHE) overview: price, valuation and scorecardAll health care companies by market value

Chemed earnings per share (EPS): questions and answers

What is Chemed's diluted earnings per share?

Chemed (CHE) reported diluted earnings per share of $18.34 in fiscal 2025 (the year ended December 31, 2025). That is 7.8% lower than the $19.89 of fiscal 2024.

What is the growth rate of Chemed's diluted earnings per share?

Over the five fiscal years to 2025 diluted earnings per share shrank at a compound 1.2% a year; over ten years the rate was 11.2% a year.

What are the highest and lowest diluted earnings per share figures on record for Chemed?

Across the 18 fiscal years on record (2008–2025), the highest was $19.89 in fiscal 2024 and the lowest $2.88 in fiscal 2008.

How is Chemed's diluted earnings per share calculated?

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Chemed (CHE) earnings per share (EPS)”, data as of 17 November 2026. https://funkfolio.com/stock/CHE/eps

Underlying data: the company's filings with the SEC and Yahoo Finance.